 | Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
finance.yahoo.com - July 18 at 3:11 PM |
 | Leerink Swann Comments on Gilead Sciences, Inc.'s Q2 2018 Earnings (GILD)
www.americanbankingnews.com - July 18 at 7:42 AM |
| Cramer's charts suggest big-name biotech stocks Gilead and Celgene have more room to run
finance.yahoo.com - July 18 at 5:04 AM |
 | Gilead's HIV Franchise Under Assault As It Stares Down Paradigm-Changing Drug
seekingalpha.com - July 17 at 3:09 PM |
| Your 52 Top Yield, Upside, And Net Gain Nasdaq Stocks For July
seekingalpha.com - July 17 at 5:13 AM |
| Gilead Sciences (GILD) to Release Earnings on Tuesday
www.americanbankingnews.com - July 17 at 3:46 AM |
| Gilead Sciences, Inc. (GILD) Short Interest Update
www.americanbankingnews.com - July 14 at 4:06 PM |
| Gilead's Hot Stock May Have Further to Rise
finance.yahoo.com - July 14 at 3:20 PM |
| Gilead Sciences to Release Second Quarter 2018 Financial Results on Wednesday, July 25, 2018
finance.yahoo.com - July 14 at 3:20 PM |
| 3 Biotech Stocks With Big News Coming in NASH
finance.yahoo.com - July 14 at 3:20 PM |
| Gilead: Cheap Valuation For Great Pipeline
seekingalpha.com - July 12 at 3:06 PM |
| If You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It
finance.yahoo.com - July 12 at 8:49 AM |
 | If You're Thinking About Buying Gilead Sciences Stock, Now's the Time to Do It
www.fool.com - July 12 at 6:31 AM |
| Equities Analysts Issue Forecasts for Gilead Sciences, Inc.'s Q2 2018 Earnings (GILD)
www.americanbankingnews.com - July 11 at 9:05 AM |
| The Zacks Analyst Blog Highlights: Mastercard, Gilead, Goldman Sachs, PepsiCo and Aetna
finance.yahoo.com - July 10 at 3:12 PM |
 | Trade of the Day: Gilead Sciences (GILD)
investorplace.com - July 10 at 9:48 AM |
 | Bullish Two Hundred Day Moving Average Cross - GILD
www.nasdaq.com - July 10 at 5:06 AM |
| Michael Amoroso to Join Kite as Senior Vice President and Head of Worldwide Commercial, Cell Therapy
finance.yahoo.com - July 10 at 5:06 AM |
| Gilead Sciences Near-Term Data Release For Rheumatoid Arthritis Is An Important Event
seekingalpha.com - July 9 at 3:11 PM |
| Gilead Q2 Results Could Initiate A Rally
seekingalpha.com - July 9 at 3:11 PM |
| Top Research Reports for Mastercard, Gilead & Goldman Sachs
finance.yahoo.com - July 9 at 3:11 PM |
| Zacks: Brokerages Anticipate Gilead Sciences, Inc. (GILD) Will Announce Quarterly Sales of $5.17 Billion
www.americanbankingnews.com - July 8 at 2:58 AM |
| Noteworthy Friday Option Activity: GILD, OMC, ADSK
www.nasdaq.com - July 6 at 3:08 PM |
| Gilead Sciences Is Displaying a Bullish Long-Term Pattern
finance.yahoo.com - July 6 at 3:08 PM |
| Biotech Stocks Rally on Biogen's Landmark Test
finance.yahoo.com - July 6 at 3:08 PM |
| 7 Stocks That Can Lead The Market Longterm
finance.yahoo.com - July 6 at 3:08 PM |
| Gilead Sciences, Inc. (GILD) Expected to Post Earnings of $1.53 Per Share
www.americanbankingnews.com - July 6 at 2:08 PM |
| Biotech Stock Roundup: GILD's Positive CHMP Nod, Regulatory Updates & More
finance.yahoo.com - July 6 at 5:21 AM |
| Gilead Sciences, Inc. (GILD) Director John C. Martin Sells 50,000 Shares
www.americanbankingnews.com - July 5 at 9:14 PM |
| Gilead: A Top Biotech Pick for a Turnaround
finance.yahoo.com - July 5 at 3:15 PM |
 | Is Gilead Sciences a Great Stock for Value Investors?
www.zacks.com - July 3 at 9:02 AM |
| Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion
finance.yahoo.com - July 2 at 4:39 PM |
| Gilead's (GILD) CAR T Therapy Gets Positive CHMP Opinion
finance.yahoo.com - July 2 at 4:39 PM |
| Rival Novartis, Gilead CAR-T therapies win European panel recommendation
finance.yahoo.com - June 30 at 10:41 AM |
| Rival Novartis, Gilead CAR-T therapies win CHMP recommendations
seekingalpha.com - June 30 at 10:41 AM |
| Head-To-Head Analysis: Gilead Sciences (GILD) versus Genocea Biosciences (GNCA)
www.americanbankingnews.com - June 29 at 6:30 PM |
| 5 Undervalued Large-Cap Stocks For Value Investors - June 2018
seekingalpha.com - June 28 at 3:17 PM |
| Raymond James initiates Gilead at 35% upside
seekingalpha.com - June 28 at 3:17 PM |
| Gilead Sciences (GILD) Now Covered by Raymond James
www.americanbankingnews.com - June 28 at 12:19 PM |
| Here Are 43 Of 84 'Safer' Healthcare High Yield Dividend Equities For June
seekingalpha.com - June 27 at 5:52 AM |
| Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection
finance.yahoo.com - June 26 at 3:16 PM |
| Gilead's (GILD) Biktarvy Gets EC Nod for HIV- 1 Infection
finance.yahoo.com - June 26 at 3:16 PM |
 | Gilead Sciences (GILD) Announces EC Granted Marketing Authorization for its Biktarvy for Treatment of HIV-1 Infection
www.streetinsider.com - June 26 at 5:16 AM |
| EC Grants Authorization For Gilead's Biktarvy For Treatment Of HIV-1 Infection
www.nasdaq.com - June 25 at 3:13 PM |
| European Commission Grants Marketing Authorization for Gilead’s Biktarvy® (Bictegravir, Emtricitabine, Tenofovir Alafenamide) for the Treatment of HIV-1 Infection
finance.yahoo.com - June 25 at 3:13 PM |
| Gilead Sciences, Inc. (GILD) Receives Consensus Recommendation of "Buy" from Analysts
www.americanbankingnews.com - June 25 at 11:37 AM |
| Cramer's lightning round: I don't like Snap's ownership structure
finance.yahoo.com - June 23 at 6:08 AM |
| 3 Big Biotechs That Can Beat the Market
finance.yahoo.com - June 21 at 3:21 PM |
| Gilead Sciences Inc (NASDAQ:GILD): Should The Recent Earnings Drop Worry You?
finance.yahoo.com - June 21 at 3:21 PM |
| Gilead Sciences, Inc. (GILD) Expected to Announce Quarterly Sales of $5.15 Billion
www.americanbankingnews.com - June 21 at 4:10 AM |
